D/C/F/TAF
FDA Approves Symtuza, the First Complete Darunavir-Based, Single-Tablet Regimen for HIV
The FDA recently approved Janssen's Symtuza, the first complete darunavir-based, single-tablet regimen for the ...
JULY 19, 2018
Switching to a D/C/F/TAF Regimen
Gregory D. Huhn, MD, discusses an analysis of 48-week data from the EMERALD trial in subgroups based on age, gender ...
MAY 30, 2018
Load more